Unicancer Early Phase Group (GEP)

With its phase I and phase II trials, the UNICANCER Early Phase Group provides patients with early access to innovative treatments.

President: Dr Thomas BACHELOT, Léon Bérard Centre, Lyon

 

 

The Unicancer Early Phase Group has become an important player in France, acknowledged by academic and industrial partners for the quality of its phase I and phase II trials. It is committed to providing patients with early access to innovative treatments. It designs increasingly complex trials according to the latest methodologies and research developed in the area of precision medicine.

 

 

Contact

Marta Jimenez, Personalized Medicine and Early Trials Programmes Head

Please email us for more information